Impact of Chemotherapy Delay on Overall Survival for AML with IDH1/2 Mutations: A Study in Adult Chinese Patients

The effect of time from diagnosis to treatment (TDT) on overall survival of patients with acute myeloid leukemia (AML) remains obscure. Furthermore, whether chemotherapy delay impacts overall survival (OS) of patients with a special molecular subtype has not been investigated. Here, we enrolled 364...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing-Han, Guo, Qi, Ma, Zhi-Xin, Ma, Qiu-Ling, Yu, Meng-Xia, Yin, Xiu-Feng, Lu, Sha-Sha, Xie, Hong-Qiong, Jiang, Yue-Hong, Shen, Dan, Ma, Li-Ya, Shi, Hui, Yu, Wen-Juan, Lou, Ye-Jiang, Li, Ying, Yang, Min, Xu, Gai-Xiang, Mao, Li-Ping, Li, Jian-Hu, Wang, Huan-Ping, Wang, Dong-Mei, Wei, Ju-Ying, Tong, Hong-Yan, Huang, Jian, Jin, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605653/
https://www.ncbi.nlm.nih.gov/pubmed/26466372
http://dx.doi.org/10.1371/journal.pone.0140622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605653/
https://www.ncbi.nlm.nih.gov/pubmed/26466372
http://dx.doi.org/10.1371/journal.pone.0140622

Ejemplares similares